Single-Cell RNA-Seq Identifies Dynamic Cardiac Transition Program from ADCs Induced by Leukemia Inhibitory Factor
Jiayi Yao1, Feiyang Ma2,3, Li Zhang1
1Division of Cardiology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA.
Stem Cells (Dayton, Ohio)
|July 27, 2022
Summary
Leukemia inhibitory factor (LIF) induces cardiac transition in adipose-derived cells (ADCs). This study reveals distinct ADC subpopulations and a time-dependent process involving Nrf2 signaling, leading to cardiomyocyte-like cells.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Cardiovascular research
Background:
- Adipose-derived cells (ADCs) show potential for cardiac regeneration due to abundant reserves.
- Low efficiency in ADC-cardiac transition is attributed to cellular heterogeneity and unclear mechanisms.
- Leukemia inhibitory factor (LIF) is investigated as an inducer for ADC cardiomyogenesis.
Purpose of the Study:
- To investigate ADC heterogeneity and cellular kinetics during LIF-induced cardiac transition.
- To elucidate the mechanisms underlying ADC-myogenesis and cell fate determination.
- To identify factors influencing the efficiency of cardiac regeneration from ADCs.
Main Methods:
- Single-cell RNA sequencing of 39,432 ADCs undergoing LIF-induced cardiac transition.
- Analysis of cellular kinetics and gene expression patterns.
- Pseudotime analysis to map cell trajectories and identify distinct cell populations.
Main Results:
- Identified distinct ADC subpopulations with differential responses to LIF during cardiomyogenesis.
- Demonstrated that ADC-myogenesis is time-dependent and initiated by transient Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) signaling.
- Pseudotime analysis revealed two main cell fate trajectories: activated myofibroblasts and cardiomyocyte-like cells.
Conclusions:
- High-resolution insights into ADC heterogeneity and cell fate during cardiac transition.
- Understanding the role of Nrf2 signaling in initiating cardiomyogenesis.
- Provides a foundation for improving cardiac regeneration strategies using ADCs.
Keywords:
ADCadiposecardiac transitioncell sequencingderived cellsleukemia inhibitory factor (LIF)single

